FDA, Covid-19
Digest more
Top News
Overview
Impacts
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
13hon MSN
The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the virus, and those older than age 65.
President Donald Trump’s administration is slated to lay out its approach to Covid vaccination at an event Tuesday that could spell major changes in what is required to get regulatory approval for immunizations.